Navigation Links
Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Date:12/10/2010

EVA patients (3.5 percent fewer [range: -1.1 percent to 11.5 percent fewer]) than Zometa treated patients had a meaningful decrease in health-related quality of life over the 18 months.  

Interim Results Demonstrate Skeletal-Related Events in Breast Cancer Patients are Associated with Considerable Health Resource Utilization (Abstract Number: P1-13-06)SREs have an adverse financial impact on healthcare systems, consuming significant resources. The first interim results from the breast cancer section (n=67) of an ongoing study assessing the health resource utilization per type of SRE (119 discreet SREs) found that pathologic fracture required the longest hospital stay (19 days, n=18), with spinal cord compression requiring the second most days (13.3 days, n=5). Additionally, radiation to bone required the most procedures (14.7, n=87), such as imaging, followed by spinal cord compression (10.4, n=5).

This section of an ongoing observational, multinational study assessed SRE-related utilization of health resources by SRE type (surgery or radiation to bone, pathologic fracture, or spinal cord compression) in breast patients with bone metastases. Data was collected on inpatient hospitalizations, length of stay, outpatient visits, emergency room (ER) visits, nursing home/long-term care facility stays, home health visits, procedures, and medications.

Acute Phase Reactions Following Treatment with Zometa or XGEVA (Abstract Number: P6-14-09) An analysis of the Phase 3 "136" data compared the potential for acute phase reactions following treatment with either Zometa or XGEVA. Results of this analysis will be presented Sunday, Dec. 12 at 7:00 a.m. CT.

About the XGEVA Phase 3 Breast Cancer SRE Prevention Study "136" Study "136" is an international, Phase 3, randomized, double-blind study comparing XGEVA with Zometa in the treatment of bone metastases in patients with advanced breast cancer to prevent SREs. Patients enrolled in the st
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Amgen to Present at Deutsche Banks 2010 BioFEST
2. Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
3. Amgen Foundation and Ashokas Changemakers Announce Finalists in Patients
4. Choices
5. Empowerment Competition
6. Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
7. Amgen Foundation Awards $4.5 Million Grant to MLA Partner Schools to Invest in LAs Promise
8. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
9. Amgen Announces Webcast of 2010 Third Quarter Financial Results
10. Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
11. Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs professionals ... where regulations are often strict and legislation is ... a demand for professionals who have a deep ... across a product lifecycle and demonstrate its use ... University of California, Irvine Extension , in partnership ...
(Date:8/31/2015)... 2015  Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... Hagerman , Chairman & CEO, and Sean Whelan , ... Mr. Hagerman and Mr. Whelan are scheduled to participate ... Boston on Wednesday, September 9, 2015 at 1:45 ... also scheduled to participate in the Robert W. Baird 2015 ...
(Date:8/31/2015)... Aug. 31, 2015  Qualcomm Incorporated (NASDAQ: ... Qualcomm Life, Inc., is collaborating with Davita ... management solutions powered by Qualcomm Life,s 2net™ Device ... enable continuous care, informed interventions and better management ... Qualcomm Life,s annual Connect 2015 ecosystem ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Diplomat to Participate in Upcoming Investor Conferences 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 2011 First Quarter Total Revenue $565 million, including $36 million ... growth for the combined company, excluding the impact of foreign exchange ... Diastat and Efudex, pro forma organic growth for the combined company ... EPS $0.02; Cash EPS $0.62 Excluding impact from ...
... 9, 2011 Medison and Samsung Electronics jointly announced ... company, a joint partnership between Korea,s leading diagnostic ultrasound ... most technologically-advanced electronics and consumer goods companies, has outlined ... leader in medical device industry. Mr. ...
Cached Medicine Technology:Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 2Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 3Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 4Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 5Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 6Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 7Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 8Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 9Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 10Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 11Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 12Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 13Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 14Samsung Medison Pledges to Become a World-Class Medical Device Company 2
(Date:8/31/2015)... Lisle, IL (PRWEB) , ... August 31, 2015 , ... ... announce that Firm Partner William Scott has been nominated by his peers to earn ... by less than five percent of attorneys in the state of Illinois. The nomination ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Vice President, Marketing and Corporate Communications. In this capacity, Michael will provide strategic ... is an industry leader in consumer-focused programs that have contributed to the company’s ...
(Date:8/31/2015)... Newton, North Carolina (PRWEB) , ... August 31, 2015 , ... ... Abernethy Laurels on Tuesday, September 1. , “Alive Inside” shadows a social ... nonprofit “MUSIC & MEMORY?.” , “It’s a documentary about bringing music to residents in ...
(Date:8/31/2015)... ... August 31, 2015 , ... David L. ... was one of the first doctors in the area to perform minimally invasive ... have been impressive: faster recovery, decreased immediate and long-term pain, and an accelerated ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... With the FCPX LUT Soft pack from ... LUT is a Lookup Table that contains a mathematical formula for modifying an image. The ... comes with 60 soft CUBE LUT files. , FCPX LUT Soft requires Final Cut ...
Breaking Medicine News(10 mins):Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2
... Leading patient safety software company to team up ... CAMBRIDGE, MA, Aug. 19 /PRNewswire/ - rL Solutions, the leading ... it will become the founding Corporate Alliance Sponsor of the ... Association. , As part of the partnership, rL Solutions will ...
... , SOMERSET, N.J., Aug. 19 The Tic ... Care (R), it will try to break the Guinness World Record(TM) in ... for charity. Cancer C are is a national nonprofit ... , , Starting today at 11 a.m. ET, individuals ...
... ... a successful strategic workforce planning process,” stated Jim Sirbasku, co-founder and CEO of Profiles ... provides guidelines for implementing each of those 6 components.” , ... Waco, TX (PRWEB) August 19, 2009 -- ...
... ... LLP is urging the manufacturers of the fentanyl or Duragesic pain patches ... potentially fatal overdose. Because of its high potency, patients who receive too much ... a fentanyl overdose. Watson Pharmaceuticals recalled one lot of its fentanyl patches on ...
... ... a group of dentists emphasizing the urgent need for dentists to screen patients for snoring ... , ... Dr. Laurence Barsh recently spoke at the first annual Somnomed Symposium in Oahu, HI to ...
... allows physicians to evaluate suspicious lesions using a variety ... information can help significantly in distinguishing benign from malignant ... published in the September issue of the American ... the study, performed at the University of Washington Medical ...
Cached Medicine News:Health News:rL Solutions to Become the Founding Corporate Alliance Sponsor of the Society for Healthcare Consumer Advocacy 2Health News:CancerCare(R) and the Tic Tac(R) Brand Attempt To Set a World Record in Times Square 2Health News:CancerCare(R) and the Tic Tac(R) Brand Attempt To Set a World Record in Times Square 3Health News:Profiles International Releases New Study Identifying Key Factors for Strategic Workforce Planning 2Health News:Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose 2Health News:Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose 3Health News:Laurence Barsh, DMD, Founder of Snoring Isn't Sexy, LLC Emphasizes Need to Evaluate and Treat Sleep Patients 2
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
ZyDoc offers a full medical transcription and documentation solution....
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: